MEI Pharma, Inc. Annual Nonoperating Income (Expense) in USD from 2011 to 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
MEI Pharma, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2011 to 2024.
  • MEI Pharma, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $345K, a 68.4% decline year-over-year.
  • MEI Pharma, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $2.49M, a 43.8% decline year-over-year.
  • MEI Pharma, Inc. annual Nonoperating Income (Expense) for 2024 was $3.24M, a 34.3% decline from 2023.
  • MEI Pharma, Inc. annual Nonoperating Income (Expense) for 2023 was $4.93M, a 76.6% decline from 2022.
  • MEI Pharma, Inc. annual Nonoperating Income (Expense) for 2022 was $21M, a 10% increase from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $3.24M -$1.69M -34.3% Jul 1, 2023 Jun 30, 2024 10-K 2024-09-19
2023 $4.93M -$16.1M -76.6% Jul 1, 2022 Jun 30, 2023 10-K 2024-09-19
2022 $21M +$1.92M +10% Jul 1, 2021 Jun 30, 2022 10-K 2023-09-26
2021 $19.1M +$40.6M Jul 1, 2020 Jun 30, 2021 10-K 2022-09-08
2020 -$21.5M Jul 1, 2019 Jun 30, 2020 10-K 2022-09-08
2012 $871K +$1.2M Jul 1, 2011 Jun 30, 2012 10-K 2012-09-18
2011 -$330K Jul 1, 2010 Jun 30, 2011 10-K 2012-09-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.